Enteric fever, encompassing typhoid and paratyphoid fever, is a systemic illness primarily caused by Salmonella enterica serotypes Typhi and Paratyphi A, B, and C. While the disease is largely preventable, it remains a significant health burden in many low- to middle-income countries. This article aims to review recent advancements in the diagnosis and management of enteric fever.
Traditional diagnostic methods, including blood culture, have limitations in sensitivity and specificity. Recent developments focus on molecular techniques such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) which offer higher sensitivity and shorter turnaround times. Additionally, serological tests such as the Typhidot and Tubex TF have shown promise in endemic areas.
Antibiotic resistance has been a growing challenge in the treatment of enteric fever. However, new-generation cephalosporins, such as ceftriaxone and cefixime, and fluoroquinolones have shown efficacy. In severe or resistant cases, azithromycin has emerged as a reliable alternative. It is crucial to base the choice of antibiotic on local resistance patterns.
Prevention is paramount in managing enteric fever. The World Health Organization recommends typhoid vaccination in high-risk areas. The newer conjugate vaccine (TCV) has shown superior efficacy and duration of protection. Furthermore, improving water quality, sanitation, and hygiene (WASH) practices can significantly reduce the burden of disease.
While challenges persist, advancements in diagnostic technologies and evolving treatment strategies have improved the management of enteric fever. Emphasizing prevention through vaccination and WASH practices is crucial. As we continue to innovate and adapt, the goal of controlling and potentially eradicating enteric fever becomes an increasingly attainable reality.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation